This activity is jointly provided by Medical Education Resources and Carden Jennings Publishing Co., Ltd.
Target Audience
This activity has been designed to meet the educational needs of urologists, medical oncologists, radiation oncologists, primary care physicians, residents, and other healthcare professionals involved in the diagnosis and management of urologic diseases.
Educational Objectives
1. Describe the latest procedural technologies to address benign prostatic hyperplasia (BPH), focusing on patient selection, minimally-invasive therapies, and treatment options
2. Assess the diagnosis and treatment of overactive bladder (OAB), contrasting currently available agents and treatment methods
3. Review effective strategies for management of general urologic health conditions such as Peyronie’s disease, incontinence, penile implant surgery, stress urinary incontinence (SUI), and other LUTS conditions
4. Describe the treatment of bladder cancer from NMIBC to MIBC
5. Assess novel imaging and treatments for renal cell mass characterization
6. Describe the latest imaging and treatment options for prostate cancer including PET radiopharmaceuticals, including PSMA PET, novel androgen pathway inhibitors, immunotherapies, radiopharmaceuticals, PARP inhibitors, and radioligand therapy
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Carden Jennings Publishing. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit:Medical Education Resources designates this live activity for a maximum of 28 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Credit: Medical Education Resources designates this live activity for a maximum of 28 ANCC nursing contact hours. Nurses will be awarded contact hours upon successful completion of the activity.
Medical Education Resources is a provider of continuing nursing education by the California Board of Registered Nursing, Provider #CEP 12299, for 28 contact hours.
Physician Assistant Credit:Medical Education Resources has been authorized by the American Academy of Physician Assistants (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 28 AAPA Category 1 CME Credits. Physician Assistants should only claim credit commensurate with the extent of their participation.
Pharmacy Credit: Medical Education Resources designates this continuing education activity for 28 contact hours (2.8 CEUs) of the Accreditation Council for Pharmacy Education.